Catalyst Crew Technologies CEO to Cancel 50% of Common Stock Holdings in Equity Restructuring
Catalyst Crew Technologies CEO Kevin Roldan Levy will cancel up to half of his restricted common shares in exchange for preferred equity, aiming to optimize the capital structure and align leadership with long-term strategic goals.
Catalyst Crew Technologies Corp. (OTC: CCTC) announced Wednesday that its Chief Executive Officer, Kevin Roldan Levy, has initiated a capital structure initiative under which up to 50% of his restricted common stock holdings are expected to be canceled in exchange for a newly designated class of preferred equity. The move is intended to optimize the company’s common equity base, enhance long-term strategic flexibility, and align executive equity participation with broader corporate development goals, according to a press release.
The company, which is transitioning into an artificial intelligence-driven healthcare technology firm focused on digital health solutions for emerging markets, believes the transaction will contribute to a more disciplined equity framework and support its evolving strategic initiatives, including future financing opportunities, strategic partnerships, and operational development.
“This initiative reflects my long-term commitment to the Company’s strategic development and disciplined capital structure management,” Levy said in the release. “As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation.”
The restructuring is expected to strengthen alignment between executive leadership and long-term corporate performance objectives while reinforcing management’s commitment to disciplined growth and shareholder-oriented development. The company is finalizing the structure and designation of the new preferred equity and expects to provide additional updates as final corporate actions are completed.
Catalyst Crew is actively executing its strategic transition into AI-enabled healthcare, with a focus on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets. The company’s initial emphasis is on Latin America, where it aims to address the growing demand for modernized healthcare delivery systems through technology development, strategic partnerships, and targeted acquisitions.
The announcement comes as Catalyst Crew, a development-stage enterprise that has not yet generated revenues from its current business direction, continues to evaluate strategic initiatives to support its long-term development. The company’s securities involve a high degree of risk, and prospective investors are urged to carefully review all risk factors and disclosures contained in the company’s filings with the U.S. Securities and Exchange Commission before making any investment decision.
For more information about Catalyst Crew Technologies and its strategic initiatives, visit https://catalystcrewai.com.